Conducting global Cancer research at scale is a complex undertaking. Running an international oncology network across 50+ countries requires rigorous coordination, strict clinical research compliance and a constant focus on protecting patient data.
Behind the scenes, this effort relies on close collaboration between multiple teams and partners worldwide, all working toward a common goal: advancing Cancer research while maintaining the highest ethical and scientific standards.
Ensuring Ethics Approval Across the Globe
Before any research collaboration can begin, each participating center must secure approval from its local Institutional Review Board (IRB). In many cases, additional validation from national scientific and ethical review bodies is also required.
This process of ethics approval clinical trials is one of the most critical steps in enabling global Cancer research. To date, 100+ ethics committees worldwide have reviewed and approved the study, each with its own regulatory framework, expectations and timelines.
Navigating Complex Legal Frameworks
Operating internationally means complying with multiple layers of regulation. The General Data Protection Regulation (GDPR) applies as a baseline for GDPR health data research. Beyond this, each country introduces its own legal requirements related to health data, clinical research and patient privacy. Ensuring alignment between European regulations and local laws is essential to maintaining full clinical research compliance across all participating regions.
Collaborating with Local Investigators and CROs
Local expertise is essential to successfully deploy multicountry clinical trials. In each new country, investigator centers and Contract Research Organizations (CROs) provide critical guidance on how to interpret and implement local regulations. These collaborations ensure that research protocols remain compliant while being adapted to the realities of each healthcare system.
Understanding Timelines and Operational Challenges
Ethics approval timelines can vary significantly depending on the country and institution. While some approvals may be obtained within three months, others can take up to two years. This variability is a defining characteristic of multicountry clinical trials and requires long-term planning, adaptability, and patience.
Building a Global Framework of Trust and Scientific Rigor
Conducting global Cancer research at this scale involves more than scientific excellence. It requires building a structured and reliable international oncology network grounded in trust, compliance, and collaboration.
Such a framework is essential to accelerating progress in Cancer research while ensuring that every step meets the highest global standards.
Updated: March 25, 2026
